Reproducibility of in‐hospital worsening heart failure event adjudication in the RELAX‐AHF‐EU trial-Reference-Cited by-同舟云学术

Reproducibility of in‐hospital worsening heart failure event adjudication in the RELAX‐AHF‐EU trial

Published:2019-07-29 Issue:12 Volume:21 Page:1661-1662
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Hallén Jonas¹,Maggioni Aldo P.²,Lopez‐De‐Sa Esteban³,Turazza Fabio M.⁴,Witte Klaus⁵,Erdmann Erland⁶,Dahlström Ulf⁷,Ertl Georg⁸,Nielsen Olav W.⁹,Sendon Jose Lopez¹⁰,Holbro Thomas¹¹,Chen Chien‐Wei¹²,Gimpelewicz Claudio¹¹,Cowie Martin R.¹³

Affiliation:

1. Novartis Norway Oslo Norway

2. Italian Association of Hospital Cardiologists (ANMCO) Research Center Florence Italy

3. Acute Cardiac Care Unit, Cardiology DepartmentLa Paz University Hospital IdiPaz, Madrid Spain

4. Cardiology Unit, IRCCS FoundationIstituto Nazionale dei Tumori Milan Italy

5. Leeds Institute of Cardiovascular and Metabolic MedicineUniversity of Leeds Leeds UK

6. Heart CenterUniversity of Cologne Cologne Germany

7. Department of Cardiology and Department of Medical and Health SciencesLinköping University Linköping Sweden

8. Comprehensive Heart Failure CenterUniversity Hospital Würzburg Germany

9. Bispebjerg University Hospital Copenhagen Denmark

10. Cardiology DepartmentLa Paz University Hospital, IdiPaz, Universidad Autonoma de Madrid Madrid Spain

11. Novartis Pharma AG Basel Switzerland

12. Novartis Pharmaceuticals CorporationEast Hanover NJ USA

13. National Heart & Lung Institute, Imperial College London London UK

Funder

Novartis

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.1574

Reference7 articles.

1. Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure

2. Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial

3. Efficacy and safety of serelaxin when added to standard of care in patients with acute heart failure: results from a PROBE study, RELAX‐AHF‐EU

4. Worsening Heart Failure Following Admission for Acute Heart Failure

5. In-hospital worsening heart failure in patients admitted for acute heart failure

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular effects of relaxin-2: therapeutic potential and future perspectives;Clinical Research in Cardiology;2023-09-18

2. Do We Need Clinical Events Committees to Adjudicate End Points?;Circulation: Heart Failure;2020-07

3. Comparison of Outcome Adjudication by Investigators and by a Central End Point Committee in Heart Failure Trials;Circulation: Heart Failure;2020-07

4. Clinical endpoint adjudication;The Lancet;2020-06